Neuraptive Therapeutics said yesterday that it raised $11.5 million in a Series A round of equity financing to support its flagship AxoFuse nerve repair system through clinical trials and to expand operations. The round was led by private equity firm New Rhein Healthcare Investors, the Lafayette, Colo.-based company said. The AxoFuse system is a novel […]